Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace:

Ivermectin to reduce malaria transmission II. Considerations regarding clinical development pathway
Chaccour, Carlos; Rabinovich, N. Regina
The development of ivermectin as a complementary vector control tool will require good quality evidence. This paper reviews the different eco-epidemiological contexts in which mass drug administration with ivermectin could be useful. Potential scenarios and pharmacological strategies are compared in order to help guide trial design. The rationale for a particular timing of an ivermectin-based tool and some potentially useful outcome measures are suggested.
Assaigs clínics
Clinical trials
cc by (c) Chaccour et al., 2017
Biomed Central

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Chaccour, Carlos; Rabinovich, N. Regina; Slater, Hannah; Canavati, Sara E.; Bousema, Teun; Lacerda, Marcus; Ter Kuile, Feiko; Drakeley, Chris; Bassat Orellana, Quique; Foy, Brian D.; Kobylinski, Kevin
Bassat Orellana, Quique; Ordi i Majà, Jaume; Vila Estapé, Jordi; Ismail, Mamudo R.; Carrilho, Carla; Lacerda, Marcus V. G.; Munguambe, Khátia; Odhiambo, Frank O.; Lell, Bertrand; Sow, Samba; Bhutta, Zulfiqar A.; Rabinovich, N. Regina; Alonso, Pedro; Menéndez, Clara
Galatas, Beatriz; Nhamussua, Lidia; Candrinho, Baltazar; Mabote, Lurdes; Cisteró, Pau; Gupta, Himanshu; Rabinovich, N. Regina; Menéndez, Clara; Macete, Eusébio; Saute, Francisco; Mayor Aparicio, Alfredo Gabriel; Alonso, Pedro; Bassat Orellana, Quique; Aide, Pedro